Summary of Key Information:

Reporting Period (Quarter/Year): Quarter ended September 30, 2026 (Q2 FY27)

Nature of Filing / Announcement: Outcome of Board Meeting - Unaudited Financial Results

Audit Opinion:

Clean/Unqualified - The independent auditor's review report stated: "nothing has come to our attention that causes us to believe that the accompanying Statement... contains any material misstatement."

Key Financial Highlights [in ₹ Million]:

Standalone Results:

Revenue from Operations: ₹8,097 (Q2 FY27) vs ₹6,734 (Q2 FY26) - 20.2% YoY growth

Total Income: ₹8,700 (Q2 FY27) vs ₹7,353 (Q2 FY26)

Net Profit: ₹1,722 (Q2 FY27) vs ₹1,528 (Q2 FY26) - 24.5% YoY growth

EPS: Basic ₹7.55, Diluted ₹7.50 (Face value ₹2 each)

Other Equity: ₹35,832 (as of September 30, 2026) vs ₹34,756 (March 31, 2026)

Cash and Cash Equivalents: ₹749 (as of September 30, 2026) vs ₹941 (March 31, 2026)

Debt: Not specifically disclosed

Consolidated Results:

Revenue from Operations: ₹15,852 (Q2 FY27) vs ₹14,213 (Q2 FY26) - 11.5% YoY growth

Total Income: ₹16,275 (Q2 FY27) vs ₹14,704 (Q2 FY26)

Net Profit: ₹1,902 (Q2 FY27) vs ₹1,822 (Q2 FY26) - 4.4% YoY growth

EPS: Basic ₹8.33, Diluted ₹8.28 (Face value ₹2 each)

Other Equity: ₹48,243 (as of September 30, 2026) vs ₹46,738 (March 31, 2026)

Cash and Cash Equivalents: ₹3,905 (as of September 30, 2026) vs ₹4,163 (March 31, 2026)

Segment-wise Performance [in ₹ Million]:

Digital and Application Services:

Revenue: ₹12,446 (Q2 FY27) vs ₹11,061 (Q2 FY26) - 12.5% YoY growth

Segment Profit: ₹1,936 (Q2 FY27) vs ₹1,872 (Q2 FY26)

Cloud Infrastructure and Security:

Revenue: ₹3,406 (Q2 FY27) vs ₹3,152 (Q2 FY26) - 8.1% YoY growth

Segment Profit: ₹627 (Q2 FY27) vs ₹637 (Q2 FY26)

Corporate Actions:

The Board approved the merger of M3BI India Private Limited with Zensar Technologies Limited effective April 1, 2027, subject to necessary approvals.

Other Significant Information:

During the quarter, BridgeView Life Sciences, LLC and M3BI LLC were merged with Zensar Technologies Inc. effective August 1, 2026 and September 1, 2026 respectively.

Subcontracting costs increased significantly to ₹1,216 million (standalone) and ₹2,777 million (consolidated) in Q2 FY27.

Employee benefits expense remained stable at ₹4,524 million (standalone) and ₹9,336 million (consolidated).